We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image
  • Published In : May 2023
  • Code : CMI3518
  • Pages :177
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

The global muscle stimulation devices market is estimated to be valued at US$  756.7 million in 2023 and is expected to exhibit a CAGR of 3.8% during the forecast period (2023-2030).

Analysts’ Views on Global Muscle Stimulation Devices Market:

To enable a platform that is rapid, efficient sample processing and the market is being driven primarily by the rising prevalence of musculoskeletal disorders and the increasing trend of physical fitness worldwide. Muscle stimulators are medical devices that use electrical impulses to contract muscles, helping to reduce pain, increase muscle strength, and promote muscle relaxation.  Global muscle stimulation devices market over the forecast period. For instance, in April 2021, Therabody, Inc. is wellness technology company, announced that it has acquired the PowerDot. Smart Muscle Stimulator. It is use for neuromuscular electrical stimulation (NMES) and transcutaneous electrical nerve stimulation (TENS) send electronic pulses to stimulate motor nerves to create muscle contraction and stimulate sensory nerves to temporarily relieve pain.  

Figure 1. Global Muscle Stimulation Devices Market Share (%), by Product Type, 2023

MUSCLE STIMULATION DEVICES MARKET

To learn more about this report, request a free sample copy

Global muscle stimulation devices market – Driver

Increasing incidence of head and spinal cord injuries

Increasing incidence of head and spinal cord injuries is expected to boost growth of the global muscle stimulation devices market over the forecast period. For instance, According to National Library of Medicine in May 2022, Globally, between 250,000 and 500,000 patients, each year suffer a spinal cord injury. Most of these cases are due to preventable causes such as violence and motor vehicle accidents. In the U.S., there are approximately 17,000 new cases of spinal cord injuries each year, and roughly 282,000 persons are estimated to be living with spinal cord injuries.

Figure 2. Global Muscle Stimulation Devices Market Value (US$ Million), by Region, 2023

MUSCLE STIMULATION DEVICES MARKET

To learn more about this report, request a free sample copy

Global Muscle Stimulation Devices Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global muscle stimulation devices market over the forecast period. North America is estimated to hold 47.5% of the market share in 2023. The North America muscle stimulation devices market is expected to witness significant growth in the coming years, driven by factors such as the increasing prevalence of musculoskeletal disorders and the rising demand for non-invasive and drug-free pain management therapies Thus, the rise in muscle stimulation devices market growth over the forecast period.

Global Muscle Stimulation Devices Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others are facing problems with the transportation of drugs from one place to another.

However, the COVID-19 pandemic had a positive impact on the global muscle stimulation devices market. For instance, A case study published in the journal of medicine in April 2021 reported that COVID-19 could present with exacerbated symptoms of underlying disorder such as severe gastroparesis flare in the patients. A number of patients tested positive for COVID-19 after developing muscle hardness symptoms, conjuction with respiratory symptoms.

Muscle Stimulation Devices Market Report Coverage

Report Coverage Details
Base Year: 2022 Market Size in 2023: US$ 756.7 Mn
Historical Data for: 2017 to 2021 Forecast Period: 2023 to 2030
Forecast Period 2023 to 2030 CAGR: 3.8% 2030 Value Projection: US$ 980.8 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Transcutaneous Electrical Nerve Stimulation (TENS), Interferential Current Electrical Stimulation (IFC), Burst Mode Alternating Current (BMAC), Neuromuscular Electrical Stimulation (NMES) Home Care
  • By Application: Pain Management, Neurological and Movement Disorder Management, Musculoskeletal Disorder Management
  • By End user: Hospitals, Physiotherapy Clinics, Sports Clinics, Home Care 
Companies covered:

Baptist Health, DJO Global Inc., Zynex Inc., Neurometrix Inc., R.S. Medical Inc.,Omron Corporation Medtronic plc., Abbott., Boston Scientific Corporation., BTL Corporate., Nevro Corp., Cogentix Medical and BioMedical Life Systems.

Growth Drivers:
  • Increasing incidence of head and spinal cord injuries 
  • Increasing product approvals by regulatory bodies for mucle stimulation devices
Restraints & Challenges:
  • Acceptance of alternative therapies by patients

Global Muscle Stimulation Devices Market Segmentation:

The global muscle stimulation devices market report is segmented into by Product Type,  by Application, By End User and Region.

By Product Type, the market is segmented into Transcutaneous electrical nerve stimulation (tens), Interferential current electrical stimulation (ifc), Burst mode alternating current (bmac), Neuromuscular electrical stimulation (nmes) . Out of which, the  into Transcutaneous Electrical Nerve Stimulation (TENS) segment is expected to hold a dominant position in the global muscle stimulation devices market during the forecast period and this is attributed to the technological advancements in the field of Muscle Stimulation Devices.

By Application, the market is segmented into Pain management, neurological and movement disorder management, and musculoskeletal disorder management. Out of which, the into Pain Management segment is expected to hold a dominant position in the Muscle Stimulation Devices market during the forecast period and this is attributed to the increasing prevalence of .

By End User, the market is segmented into Hospitals, Physiotherapy Clinics, Sports Clinics, and Home Care . Out of which, the Physiotherapy Clinics is expected to dominate the market over the forecast period and this is attributed to the increasing prevalence of Neurological and Movement Disorder.

Among all the segmentations, the product type segment has the highest potential due to the increasing prevalence of neurological and movement disorder  over the forecast period. Baptist Health neurologist and neurosurgeon work with Medtronic to offer minimally invasive treatment for placement of deep brain stimulation neurotransmitters to individualize care for patients based on their neurological condition. Deep brain stimulation (DBS) devices are effective for managing movement disorders such as Parkinson’s disease and other neurological conditions, Baptist Health worked with Medtronic to pioneer an innovative medical device aimed at improving quality of life for patients with severe neurologic disorders.

Global Muscle Stimulation Devices Market Cross Sectional Analysis:

Rising incidence of Neurological and Movement Disorder  in emerging economies is also expected to boost demand for muscle stimulant device technologies in North America region. For instance, in May  2021, Zynex Inc is manufacturing and marketing of medical devices, launched NeuroMove is U.S. FDA-cleared for stroke rehabilitation, and its use has dramatically ameliorated functional impairments in stroke survivors in many clinical studies and in the clinical practice.

Global Muscle Stimulation Devices Market: Key Developments

In May 2021, ITO CO., LTD., is Japan-based engineering and manufacturers and electrophysical agents announced that electrical muscle stimulator for TMJ (temporomandibular joint) Pain Relief "D function" had received 510(k) clearance by the U.S. FDA. Its use for Prevents and reveres muscle atrophy (loss of muscle mass/tissue) Enhances rehabilitation of muscles. Increases range of motion for tense muscles or tendons. Reduces stress and discomfort.

In September 2021, NCS America, Inc., is a medical technology company  announced that U.S. Food and Drug Administration (FDA) cleared the Shoulder Pacemaker and its unique Motion Activated Stimulation (MAS) technology. The Shoulder Pacemaker is an innovative wearable electro stimulator created for patients suffering from unbalanced muscle activation in the shoulder.

In October 2022, Medtronic is a medical technology, services, and solutions. The Company  launched Medtronic Neurovascular Co-Lab Platform to accelerate innovation in stroke treatment. Neurovascular Co-Lab Platform drives collaboration and connections among start-ups, physicians, and institutions; aims to improve stroke treatment and access for patients worldwide. 

In July 2021, Neurolief, an Israel-based neuromodulation company and NeuroFront, a clinical stage biotech company, announced an exclusive licensing agreement for NeuroFront to develop and commercialize Relivion, non-invasive medical devices for the treatment of migraine and depression, in China and South Korea.

Global Muscle Stimulation Devices Market: Key Trends

Rising demand of stimulation device, increasing need to treat paralytic patients and surging demand of combination therapy can drive the growth of market

Rising demand of stimulation device, increasing need to treat paralytic patients and surging demand of combination therapy, the muscle stimulation devices market is expected to experience considerable expansion in the North American region. For instance, on April 10, 2023, Reach Neuro, Inc. is Medical equipment manufacturer in Pittsburgh, Pennsylvania. received breakthrough device designation from the U.S. Food and Drug Administration (FDA) for its Avantis system directly restores a patient’s ability to control movement and upper body paralysis treatment for stroke patients.

Global Muscle Stimulation Devices Market: Restraint

Side effects of transcutaneous electrical nerve stimulation (TENS) therapy

Side effects of transcutaneous electrical nerve stimulation (TENS) therapy is slated to hinder market expansion. The side effects associated with transcutaneous electrical nerve stimulation therapy include buzzing, tingling, or prickling sensation, which some people may find uncomfortable as TENS unit produces electrical impulses.  

 Global Muscle Stimulation Devices Market - Key Players

Major players operating in the global muscle stimulation devices market include DJO Global Inc., Zynex Inc., Neurometrix Inc., R.S. Medical Inc., Omron Corporation Medtronic plc., Abbott., Boston Scientific Corporation., BTL Corporate., Nevro Corp., Cogentix Medical , Acumedical , Beijing Electronics Holding, Enovis, Nasophlex and BioMedical Life Systems.

*Definition: Muscle Stimulation Devices is a study of electrical muscle stimulation to help treat pain and heal injured, weak, or diseased muscles. The electrical currents may help improve blood flow and stimulate the muscle fibers or nerves.Physicians may recommend TENS or EMS depending on the injury or condition.EMS may help the muscles respond to natural signals to contract. This response helps strengthen or retrain a muscle after surgery or an injury. Healthcare professionals may recommend TENS therapy to help increase blood flow to the area and reduce pain. This technique help muscle firing patterns.There are also other uses for electrical muscle stimulation, including as an aid for weight loss and physical therapy.

Frequently Asked Questions

The global muscle stimulation devices market is estimated to be valued at US$ 756.7 million in 2023 and is expected to exhibit a CAGR of 3.8% between 2023 and 2030.

Increasing incidence of head and spinal cord injuries and Increasing product approvals by regulatory bodies for mucle stimulation devices  to expand the product portfolio is expected to drive the market growth.

Transcutaneous Electrical Nerve Stimulation (TENS) is the leading segment in the market.

Acceptance of alternative therapies by patients expected to hinder the market over the forecast period.

Major players operating in the market include Baptist Health , DJO Global Inc., Zynex Inc. , Neurometrix Inc., R.S. Medical Inc.,Omron Corporation Medtronic plc., Abbott., Boston Scientific Corporation., BTL Corporate., Nevro Corp., Cogentix Medical and BioMedical Life Systems

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount
Logo

Reliability and Reputation

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Reliability and Reputation

27001:2022

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo